| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |